(Total Views: 632)
Posted On: 10/17/2025 1:36:16 PM
Post# of 158035
"LS-variant anti-CCR5 monoclonal antibody provides long-lasting
protection against intrarectal SHIV acquisition in rhesus macaques""
Recent presentation:
Poster
https://www.google.com/url?sa=t&source=we...lq2EnIJYLj
"These data demonstrate the ability of LS-variant Leronlimab to provide long-term protection against intrarectal SHIV acquisition and support development of long-acting CCR5 blockade for HIV PrEP.
protection against intrarectal SHIV acquisition in rhesus macaques""
Recent presentation:
Poster
https://www.google.com/url?sa=t&source=we...lq2EnIJYLj
"These data demonstrate the ability of LS-variant Leronlimab to provide long-term protection against intrarectal SHIV acquisition and support development of long-acting CCR5 blockade for HIV PrEP.
(10)
(0)
